CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 87 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,000 | -25.0% | 1,034 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 1,034 | +106.8% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | -88.5% | 500 | -85.9% | 0.00% | -75.0% |
| Q3 2018 | $52,000 | +36.8% | 3,545 | +54.8% | 0.00% | +33.3% |
| Q2 2018 | $38,000 | -77.6% | 2,290 | -65.3% | 0.00% | -81.2% |
| Q4 2017 | $170,000 | +23.2% | 6,608 | -18.7% | 0.02% | +14.3% |
| Q1 2017 | $138,000 | – | 8,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |